Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04230941 · ClinicalTrials.gov registry record · NA
Memory and Attention Adaptation Training-Geriatrics (MAAT-G)
A NA study, sponsored by University of Rochester.
- Completed
- Registry status
- NA
- Development phase
- 4
- Enrollment target
NCT04230941 is a NA study that has completed, run by University of Rochester. The registered enrollment target is 4 participants.
The verdict
NCT04230941, a NA study, has completed, sponsored by University of Rochester.
- COMPLETED
- Registry status
- NA
- Development phase
- 4 participants
- Enrollment target
Study Summary
Cancer-related cognitive dysfunction (CRCD) affects up to 75% of patients receiving chemotherapy and older adults are at greater risk of developing CRCD, which can negatively affect their functional independence and quality of life. Memory and Attention Adaptation Training (MAAT) is a promising treatment for CRCD that improves perceived cognition in younger cancer survivors, but needs to be adapted for older adults to address their unique needs. The proposed study will adapt MAAT for older adults using feedback from key stakeholders (older adults with cancer and their caregivers), and test usability of the intervention.
Interventions
- BEHAVIORAL MAAT-G
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2020-06-12 |
| Est. Completion | 2022-02-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04230941
The ClinicalTrials.gov registry entry for NCT04230941 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 4 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Rochester, which has 636 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which MAAT-G is the first listed.
NCT04230941 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04230941 about?
NCT04230941 is a clinical study titled "Memory and Attention Adaptation Training-Geriatrics (MAAT-G)". Cancer-related cognitive dysfunction (CRCD) affects up to 75% of patients receiving chemotherapy and older adults are at greater risk of developing CRCD, which can negatively affect their functional independence and quality of life. Memory and Attention Adaptation Training (MAAT) is a promising trea...
What is the current status of trial NCT04230941?
This trial is currently completed. It is a NA study. The enrollment target is 4 participants. The study started on 2020-06-12. Estimated completion is 2022-02-01.
What interventions are being tested in trial NCT04230941?
The interventions under investigation include: MAAT-G (BEHAVIORAL).
Who is sponsoring clinical trial NCT04230941?
This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.